Literature DB >> 8920887

A proinflammatory activity of interleukin 8 in human skin: expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes.

D Bruch-Gerharz1, K Fehsel, C Suschek, G Michel, T Ruzicka, V Kolb-Bachofen.   

Abstract

Psoriasis is a common chronic skin disease mediated by cellular immune mechanisms and characterized by an intense neutrophil cell infiltrate and proliferative activation of epidermal keratinocytes. We have previously described the expression of the inducible nitric oxide synthase (iNOS) in epidermal keratinocytes of psoriatic skin lesions. In this study, the role of iNOS in psoriatic inflammation was explored ex vivo in psoriatic skin biopsies and in vitro in primary cultures of human keratinocytes. Messenger RNA for the iNOS enzyme (iNOS mRNA) was detected by reverse transcriptase polymerase chain reaction in skin biopsies from patients with psoriasis, but not in skin specimens from patients with atopic eczema or from healthy volunteers. As demonstrated by in situ hybridization and immunohistochemistry, expression of iNOS mRNA and its gene product was localized to the epidermal keratinocytes of psoriatic skin lesions. In situ hybridization further revealed a complete colocalization of mRNA expression for iNOS with interleukin (IL) 8 receptor-specific mRNA either in the basal germinative cell layer or at focal sites of ongoing neutrophil inflammation in suprabasal cell layers. Because psoriatic keratinocytes have previously been shown to express mRNA transcripts for IL-8, it seemed reasonable to hypothesize that iNOS expression could be induced in an autocrine loop by IL-8. This hypothesis was substantiated by our in vitro experiments showing that a combination of IL-8 and interferon gamma induces the expression of iNOS-specific mRNA and of the functional enzyme in cultured human keratinocytes. These results suggest an important role for iNOS in concert with IL-8 and its receptor early during the formation of psoriatic lesions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8920887      PMCID: PMC2192854          DOI: 10.1084/jem.184.5.2007

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

Review 1.  Nitric oxide: a pathogenetic factor in autoimmunity.

Authors:  H Kolb; V Kolb-Bachofen
Journal:  Immunol Today       Date:  1992-05

2.  Interleukin-8 inhibits the induction of nitric oxide synthase in rat peritoneal neutrophils.

Authors:  T B McCall; R M Palmer; S Moncada
Journal:  Biochem Biophys Res Commun       Date:  1992-07-31       Impact factor: 3.575

Review 3.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

Review 4.  FK506 in the treatment of inflammatory skin disease: promises and perspectives.

Authors:  G Michel; L Kemeny; B Homey; T Ruzicka
Journal:  Immunol Today       Date:  1996-03

Review 5.  Keratinocytes as initiators of inflammation.

Authors:  J N Barker; R S Mitra; C E Griffiths; V M Dixit; B J Nickoloff
Journal:  Lancet       Date:  1991-01-26       Impact factor: 79.321

Review 6.  The skin immune system: progress in cutaneous biology.

Authors:  J D Bos; M L Kapsenberg
Journal:  Immunol Today       Date:  1993-02

7.  Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1/IL-8 mRNA in situ.

Authors:  R Gillitzer; R Berger; V Mielke; C Müller; K Wolff; G Stingl
Journal:  J Invest Dermatol       Date:  1991-07       Impact factor: 8.551

8.  Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis.

Authors:  B J Nickoloff; G D Karabin; J N Barker; C E Griffiths; V Sarma; R S Mitra; J T Elder; S L Kunkel; V M Dixit
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

Review 9.  Nitric oxide as a secretory product of mammalian cells.

Authors:  C Nathan
Journal:  FASEB J       Date:  1992-09       Impact factor: 5.191

10.  Epidermal cyclic GMP is increased in psoriasis lesions.

Authors:  K Adachi; T Aoyagi; O Nemoto; K M Halprin; V Levine
Journal:  J Invest Dermatol       Date:  1981-01       Impact factor: 8.551

View more
  29 in total

1.  Characterization of cationic amino acid transporters (hCATs) 1 and 2 in human skin.

Authors:  Kristin Jaeger; Friedrich Paulsen; Johannes Wohlrab
Journal:  Histochem Cell Biol       Date:  2008-01-03       Impact factor: 4.304

Review 2.  Inducible nitric oxide synthase in human diseases.

Authors:  K D Kröncke; K Fehsel; V Kolb-Bachofen
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

3.  Biochemical and Biophysical Cues in Matrix Design for Chronic and Diabetic Wound Treatment.

Authors:  Yun Xiao; Samad Ahadian; Milica Radisic
Journal:  Tissue Eng Part B Rev       Date:  2016-08-19       Impact factor: 6.389

4.  Liver infiltrating T lymphocytes express interferon gamma and inducible nitric oxide synthase in chronic hepatitis C virus infection.

Authors:  S Schweyer; S Mihm; H J Radzun; H Hartmann; A Fayyazi
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

5.  Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions.

Authors:  W L Trepicchio; M Ozawa; I B Walters; T Kikuchi; P Gilleaudeau; J L Bliss; U Schwertschlag; A J Dorner; J G Krueger
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

6.  Increased levels in vivo of mRNAs for IL-8 and macrophage inflammatory protein-1 alpha (MIP-1 alpha), but not of RANTES mRNA in peripheral blood mononuclear cells of patients with atopic dermatitis (AD).

Authors:  Y Hatano; K Katagiri; S Takayasu
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

7.  Sphingosine 1-phosphate protects primary human keratinocytes from apoptosis via nitric oxide formation through the receptor subtype S1P₃.

Authors:  Elisabeth I Schmitz; Henrik Potteck; Melanie Schüppel; Marianti Manggau; Elly Wahydin; Burkhard Kleuser
Journal:  Mol Cell Biochem       Date:  2012-08-17       Impact factor: 3.396

8.  Free radical production requires both inducible nitric oxide synthase and xanthine oxidase in LPS-treated skin.

Authors:  Kozo Nakai; Maria B Kadiiska; Jin-Jie Jiang; Krisztian Stadler; Ronald P Mason
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-14       Impact factor: 11.205

9.  Toll-like receptors 2, 3 and 4 (TLR-2, TLR-3 and TLR-4) are expressed in the microenvironment of human acquired cholesteatoma.

Authors:  Mirosław Szczepański; Witold Szyfter; Renata Jenek; Maciej Wróbel; Iwona Mozer Lisewska; Jan Zeromski
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-03-15       Impact factor: 2.503

10.  Inhibitory effect of the extracts from Thai medicinal plants on iNOS expression in mouse macrophage RAW 264.7.

Authors:  Tomonori Nakamura; Naoko Kodama; Takuya Kumamoto; Yoshihiro Higuchi; Chaiyo Chaichantipyuth; Koichi Ueno; Tsutomu Ishikawa; Shingo Yano
Journal:  J Nat Med       Date:  2008-07-15       Impact factor: 2.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.